Antimicrobial Agents and Chemotherapy, 1098-6596

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection

    Jeremy J. Lim, Anna C. Nilsson, Michael Silverman, Nimer Assy, Priya Kulkarni, Jacqueline M. McBride, Rong Deng, Chloe Li, Xiaoying Yang, Allen Nguyen, Priscilla Horn, Mauricio Maia, Aide Castro, Melicent C. Peck, Joshua Galanter, Tom Chu, Elizabeth M. Newton & Jorge A. Tavel, 2020, I : Antimicrobial Agents and Chemotherapy. 64, 7, e00352-20.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. ESBL-producing Enterobacterales in patients with traveller's diarrhoea - a cross sectional cohort study.

    Oskar Ljungquist, Angela Camporeale, Shoeib Nematzadeh, Christian G. Giske, Fredrik Resman, Kristian Riesbeck & Johan Tham, 2020, I : Antimicrobial Agents and Chemotherapy.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2019
  5. A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis

    Virginia Meikle, Ann-Kristin Mossberg, Avishek Mitra, Anders P Hakansson & Michael Niederweis, 2019 feb 1, I : Antimicrobial Agents and Chemotherapy. 63, 2, e01846-18.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2018
  7. Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

    Claudio U. Köser, Jan Heyckendorf, Sönke Andres, Ioana D. Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A. Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J. Peacock, Stefan Niemann, Christoph Lange & Matthias Merker, 2018 aug 1, I : Antimicrobial Agents and Chemotherapy. 62, 8, e00616-18.

    Forskningsoutput: TidskriftsbidragLetter

  8. What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis

    Jan Heyckendorf, Sönke Andres, Claudio U. Köser, Ioana D. Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A. Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J. Peacock, Stefan Niemann, Christoph Lange & Matthias Merkerb, 2018 feb 1, I : Antimicrobial Agents and Chemotherapy. 62, 2, e01550-17.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2017
  10. 2016
  11. Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii

    Mya Thandar, Rolf Lood, Benjamin Y. Winer, Douglas R. Deutsch, Chad W. Euler & Vincent A. Fischetti, 2016, I : Antimicrobial Agents and Chemotherapy. 60, 5, s. 2971-2979 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2015
  13. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model

    Rolf Lood, Benjamin Y Winer, Adam J Pelzek, Roberto Diez-Martinez, Mya Thandar, Chad W Euler, Raymond Schuch & Vincent A Fischetti, 2015 jan 20, I : Antimicrobial Agents and Chemotherapy. 59, 4, s. 1983-91

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. LTX-109 is a Novel Agent for Nasal Decolonisation of Methicillin Resistant and Sensitive Staphylococcus aureus.

    Anna Nilsson, Håkan Janson, Hedda Wold, Anders Fugelli, Karin Andersson, Camilla Håkangård, Pernilla Olsson & Wenche Marie Olsen, 2015, I : Antimicrobial Agents and Chemotherapy. 59, 1, s. 145-151

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2014
  16. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia

    Rolf Lood, Assaf Raz, Henrik Molina, Chad W Euler & Vincent A Fischetti, 2014 mar 17, I : Antimicrobial Agents and Chemotherapy. 58, 6, s. 3073-84

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Evaluation of intra- and extracellular activity of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

    L Davies Forsman, T Schön, U S H Simonsson, J Bruchfeld, M Larsson, P Juréen, Erik Sturegård, C G Giske & K Angeby, 2014, I : Antimicrobial Agents and Chemotherapy. 58, 12, s. 7557-7559

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2012
  19. Increase of beta-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010

    Fredrik Resman, Mikael Ristovski, Arne Forsgren, Bertil Kaijser, Goran Kronvall, Patrik Medstrand, Eva Melander, Inga Odenholt & Kristian Riesbeck, 2012, I : Antimicrobial Agents and Chemotherapy. 56, 8, s. 4408-4415

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing

    J. Werngren, Erik Sturegård, P. Jureen, K. Angeby, S. Hoffner & T. Schon, 2012, I : Antimicrobial Agents and Chemotherapy. 56, 3, s. 1253-1257

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2011
  22. Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin.

    Viveka Schaar, Therése Nordström, Matthias Mörgelin & Kristian Riesbeck, 2011, I : Antimicrobial Agents and Chemotherapy. 55, s. 3845-3853

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Structure-Activity Studies and Therapeutic Potential of Host Defense Peptides of Human Thrombin

    Gopinath Kasetty, Praveen Papareddy, Martina Kalle, Victoria Rydengård, Matthias Mörgelin, Barbara Albiger, Martin Malmsten & Artur Schmidtchen, 2011, I : Antimicrobial Agents and Chemotherapy. 55, 6, s. 2880-2890

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2010
  25. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus

    Anu Daniel, Chad Euler, Mattias Collin, Peter Chahales, Kenneth J. Gorelick & Vincent A. Fischetti, 2010 apr 1, I : Antimicrobial Agents and Chemotherapy. 54, 4, s. 1603-1612 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Molecular Epidemiology of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion

    Orjan Samuelsen, Mark A. Toleman, Arnfinn Sundsfjord, Johan Rydberg, Truls M. Leegaard, Mats Walder, Astrid Lia, Trond E. Ranheim, Yashas Rajendra, Nils O. Hermansen, Timothy R. Walsh & Christian G. Giske, 2010, I : Antimicrobial Agents and Chemotherapy. 54, 1, s. 346-352

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2009
  28. Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37

    Adam A. Stroemstedt, Mukesh Pasupuleti, Artur Schmidtchen & Martin Malmsten, 2009, I : Antimicrobial Agents and Chemotherapy. 53, 2, s. 593-602

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2008
  30. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial

    Helena M Linge, Mattias Collin, Pontus Nordenfelt, Matthias Mörgelin, Martin Malmsten & Arne Egesten, 2008 jul, I : Antimicrobial Agents and Chemotherapy. 52, 7, s. 2599-2607 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Anti-HIV activity of the small modified amino acid {alpha}-hydroxy glycineamide on in vitro and in vivo HIV-1 capsid assembly and infectivity

    Samir Abdurahman, Ákos Végvári, Masoud Youssefi, Michael Levi, Stefan Höglund, Elin Andersson, Peter Horal, Bo Svennerholm, Jan Balzarini & Anders Vahlne, 2008, I : Antimicrobial Agents and Chemotherapy. 52, 10, s. 3737-3744

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2007
  33. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion.

    Sushma Singh, Angana Mukherjee, Alex R Khomutov, Lo Persson, Olle Heby, Mitali Chatterjee & Rentala Madhubala, 2007, I : Antimicrobial Agents and Chemotherapy. 51, s. 528-534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Deoxyribonucleoside kinases activate nucleoside antibiotics in severe pathogenic bacteria.

    Michael Sandrini, Oonagh Shannon, Anders Ranegaard Clausen, Lars Björck & Jure Piskur, 2007, I : Antimicrobial Agents and Chemotherapy. 51, 8, s. 2726-2732

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. In Vitro Activity of Lipopeptides Pal-Lys-Lys-NH2 and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-positive Cocci.

    Wojciech Kamysz, Carmela Silvestri, Oscar Cirioni, Andrea Giacometti, Alberto Licci, Agnese Della Vittoria, Marcin Okroj & Giorgio Scalise, 2007, I : Antimicrobial Agents and Chemotherapy. 51, 1, s. 354-358

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile

    T. Noren, T. Akerlund, Marlene Wullt, L. G. Burman & M. Unemo, 2007, I : Antimicrobial Agents and Chemotherapy. 51, 5, s. 1840-1843

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2006
  38. Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid

    T Noren, Marlene Wullt, T Akerlund, E Back, Inga Odenholt & L G Burman, 2006, I : Antimicrobial Agents and Chemotherapy. 50, 9, s. 3028-3032

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.

    Thorgerdur Sigurdardottir, Pia Andersson, Mina Davoudi, Martin Malmsten, Artur Schmidtchen & Mikael Bodelsson, 2006, I : Antimicrobial Agents and Chemotherapy. 50, 9, s. 2983-2989

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2005
  41. 2004
  42. 2003
  43. Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin

    Inga Odenholt, E Lowdin & O Cars, 2003, I : Antimicrobial Agents and Chemotherapy. 47, 10, s. 3352-3356

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Selection of Resistant Streptococcus pneumoniae during Penicillin Treatment In Vitro and in Three Animal Models.

    Jenny Dahl Knudsen, Inga Odenholt, Helga Erlendsdottir, Magnus Gottfredsson, Otto Cars, Niels Frimodt-Møller, Frank Espersen, Karl G. Kristinsson & Sigurdur Gudmundsson, 2003, I : Antimicrobial Agents and Chemotherapy. 47, 8, s. 2499-2506

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: In vitro kinetic model

    Inga Odenholt, I Gustafsson, E Lowdin & O Cars, 2003, I : Antimicrobial Agents and Chemotherapy. 47, 2, s. 518-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2002
  47. Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model

    Inga Odenholt, E Lowdin, I Gustafsson & O Cars, 2002, I : Antimicrobial Agents and Chemotherapy. 46, 6, s. 2046-2048

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis

    Stefan Höglund, Jin Su, Sara Sandin-Reneby, Ákos Végvári, Stellan Hjertén, Ida-Maria Sintorn, Hillary Foster, Yi-Pyng Wu, Ingela Nyström & Anders Vahlne, 2002, I : Antimicrobial Agents and Chemotherapy. 46, 11, s. 3597-3605

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. 2000
  50. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice

    Xin Wang, Roger Willén & Torkel Wadström, 2000, I : Antimicrobial Agents and Chemotherapy. 44, 9, s. 2452-2457

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 1998
  52. Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes

    Kristian Riesbeck, Arne Forsgren, Agnethe Henriksson & Anders Bredberg, 1998 aug 1, I : Antimicrobial Agents and Chemotherapy. 42, 8, s. 1923-1930 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. 1997
  54. 1995
  55. CP-115,953 stimulates cytokine production by lymphocytes

    K. Riesbeck & A. Forsgren, 1995 jan 1, I : Antimicrobial Agents and Chemotherapy. 39, 2, s. 476-483

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. 1994
  57. Limited effects of temafloxacin compared with ciprofloxacin on T- lymphocyte function

    Kristian Riesbeck & Arne Forsgren, 1994 jan 1, I : Antimicrobial Agents and Chemotherapy. 38, 4, s. 879-882

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  58. 1990
  59. Ciprofloxacin does not inhibit mitochondrial functions but other antiboitics do

    K. Riesbeck, A. Bredberg & A. Forsgren, 1990 jan 1, I : Antimicrobial Agents and Chemotherapy. 34, 1, s. 167-169

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. 1989
  61. In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida

    Elisabet Holst, Jan Rollof & Håkan Miörner, 1989, I : Antimicrobial Agents and Chemotherapy. 33, 12, s. 2142-2143

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift